DENN vs GSK · P/E 12, rev $452.3M vs P/E 13, $103.31B cap
Denny’s Corp (DENN) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Denny’s Corp (DENN) is a restaurants company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported DENN revenue for 2024-12-25 was $452.3M. Net income was $21.6M. Revenue was down 2.5% from 2023-12-27 to 2024-12-25. DENN currently screens at market cap $209.1M and trailing P/E 12.4.
GSK does not have a complete income-statement cache yet.
DENN currently screens at market cap $209.1M and trailing P/E 12.4. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the DENN and GSK stock pages for the full models.
Not investment advice.